Skip to Main Content

Paper Details

Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.
Clin Case Rep
6
2021
COVID-19, Pegylated interferon, SARS-CoV-2, SARS-CoV-2 infection, interferon, pegylated interferon, primary myelofibrosis, ruxolitinib, viral RNA, woman
Author NameAffiliation
Aaron F CarlinDivision of Infectious Disease university of california san diego Medical School San Diego CA USA.
Davey M SmithDivision of Infectious Disease university of california san diego Medical School San Diego CA USA.
  • 1 - 2

Datasets

Release 1.2